If this would be the case then HLA-G expression does not have a causal, functional role in tumour progression and therefore poor clinical patient outcome, but would rather be the consequence of these tumours possessing an aggressive phenotype (Figure 1). This evidence concerns the gene HLA-G and neoplasm.